Global Drugs for Schistosomiasis Market Insights and Forecast to 2028

Publisher Name :
Date: 21-Jan-2022
No. of pages: 97
Inquire Before Buying

Drugs for Schistosomiasis market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Drugs for Schistosomiasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Praziquantel

- Oxamniquine

- Other

Segment by Application

- S. haematobium

- S. mansoni

- S. japonicum

- S. mekongi

- S. intercalatum

By Company

- Shin Poong

- Merck

- Bayer

- EIPICO

- Chandra Bhagat Pharma

- Taj Pharmaceuticals

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Drugs for Schistosomiasis Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Drugs for Schistosomiasis Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Market by Application
1.3.1 Global Drugs for Schistosomiasis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Schistosomiasis Sales Estimates and Forecasts 2017-2028
2.2 Global Drugs for Schistosomiasis Revenue Estimates and Forecasts 2017-2028
2.3 Global Drugs for Schistosomiasis Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drugs for Schistosomiasis Sales by Region
2.4.1 Global Drugs for Schistosomiasis Sales by Region (2017-2022)
2.4.2 Global Sales Drugs for Schistosomiasis by Region (2023-2028)
2.5 Global Drugs for Schistosomiasis Revenue by Region
2.5.1 Global Drugs for Schistosomiasis Revenue by Region (2017-2022)
2.5.2 Global Drugs for Schistosomiasis Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drugs for Schistosomiasis Sales by Manufacturers
3.1.1 Global Top Drugs for Schistosomiasis Manufacturers by Sales (2017-2022)
3.1.2 Global Drugs for Schistosomiasis Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drugs for Schistosomiasis in 2021
3.2 Global Drugs for Schistosomiasis Revenue by Manufacturers
3.2.1 Global Drugs for Schistosomiasis Revenue by Manufacturers (2017-2022)
3.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drugs for Schistosomiasis Revenue in 2021
3.3 Global Drugs for Schistosomiasis Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drugs for Schistosomiasis Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs for Schistosomiasis Sales by Type
4.1.1 Global Drugs for Schistosomiasis Historical Sales by Type (2017-2022)
4.1.2 Global Drugs for Schistosomiasis Forecasted Sales by Type (2023-2028)
4.1.3 Global Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
4.2 Global Drugs for Schistosomiasis Revenue by Type
4.2.1 Global Drugs for Schistosomiasis Historical Revenue by Type (2017-2022)
4.2.2 Global Drugs for Schistosomiasis Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
4.3 Global Drugs for Schistosomiasis Price by Type
4.3.1 Global Drugs for Schistosomiasis Price by Type (2017-2022)
4.3.2 Global Drugs for Schistosomiasis Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drugs for Schistosomiasis Sales by Application
5.1.1 Global Drugs for Schistosomiasis Historical Sales by Application (2017-2022)
5.1.2 Global Drugs for Schistosomiasis Forecasted Sales by Application (2023-2028)
5.1.3 Global Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
5.2 Global Drugs for Schistosomiasis Revenue by Application
5.2.1 Global Drugs for Schistosomiasis Historical Revenue by Application (2017-2022)
5.2.2 Global Drugs for Schistosomiasis Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
5.3 Global Drugs for Schistosomiasis Price by Application
5.3.1 Global Drugs for Schistosomiasis Price by Application (2017-2022)
5.3.2 Global Drugs for Schistosomiasis Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drugs for Schistosomiasis Market Size by Type
6.1.1 North America Drugs for Schistosomiasis Sales by Type (2017-2028)
6.1.2 North America Drugs for Schistosomiasis Revenue by Type (2017-2028)
6.2 North America Drugs for Schistosomiasis Market Size by Application
6.2.1 North America Drugs for Schistosomiasis Sales by Application (2017-2028)
6.2.2 North America Drugs for Schistosomiasis Revenue by Application (2017-2028)
6.3 North America Drugs for Schistosomiasis Market Size by Country
6.3.1 North America Drugs for Schistosomiasis Sales by Country (2017-2028)
6.3.2 North America Drugs for Schistosomiasis Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Drugs for Schistosomiasis Market Size by Type
7.1.1 Europe Drugs for Schistosomiasis Sales by Type (2017-2028)
7.1.2 Europe Drugs for Schistosomiasis Revenue by Type (2017-2028)
7.2 Europe Drugs for Schistosomiasis Market Size by Application
7.2.1 Europe Drugs for Schistosomiasis Sales by Application (2017-2028)
7.2.2 Europe Drugs for Schistosomiasis Revenue by Application (2017-2028)
7.3 Europe Drugs for Schistosomiasis Market Size by Country
7.3.1 Europe Drugs for Schistosomiasis Sales by Country (2017-2028)
7.3.2 Europe Drugs for Schistosomiasis Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs for Schistosomiasis Market Size by Type
8.1.1 Asia Pacific Drugs for Schistosomiasis Sales by Type (2017-2028)
8.1.2 Asia Pacific Drugs for Schistosomiasis Revenue by Type (2017-2028)
8.2 Asia Pacific Drugs for Schistosomiasis Market Size by Application
8.2.1 Asia Pacific Drugs for Schistosomiasis Sales by Application (2017-2028)
8.2.2 Asia Pacific Drugs for Schistosomiasis Revenue by Application (2017-2028)
8.3 Asia Pacific Drugs for Schistosomiasis Market Size by Region
8.3.1 Asia Pacific Drugs for Schistosomiasis Sales by Region (2017-2028)
8.3.2 Asia Pacific Drugs for Schistosomiasis Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Drugs for Schistosomiasis Market Size by Type
9.1.1 Latin America Drugs for Schistosomiasis Sales by Type (2017-2028)
9.1.2 Latin America Drugs for Schistosomiasis Revenue by Type (2017-2028)
9.2 Latin America Drugs for Schistosomiasis Market Size by Application
9.2.1 Latin America Drugs for Schistosomiasis Sales by Application (2017-2028)
9.2.2 Latin America Drugs for Schistosomiasis Revenue by Application (2017-2028)
9.3 Latin America Drugs for Schistosomiasis Market Size by Country
9.3.1 Latin America Drugs for Schistosomiasis Sales by Country (2017-2028)
9.3.2 Latin America Drugs for Schistosomiasis Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drugs for Schistosomiasis Market Size by Type
10.1.1 Middle East and Africa Drugs for Schistosomiasis Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Type (2017-2028)
10.2 Middle East and Africa Drugs for Schistosomiasis Market Size by Application
10.2.1 Middle East and Africa Drugs for Schistosomiasis Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Application (2017-2028)
10.3 Middle East and Africa Drugs for Schistosomiasis Market Size by Country
10.3.1 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shin Poong
11.1.1 Shin Poong Corporation Information
11.1.2 Shin Poong Overview
11.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shin Poong Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shin Poong Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 EIPICO
11.4.1 EIPICO Corporation Information
11.4.2 EIPICO Overview
11.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 EIPICO Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 EIPICO Recent Developments
11.5 Chandra Bhagat Pharma
11.5.1 Chandra Bhagat Pharma Corporation Information
11.5.2 Chandra Bhagat Pharma Overview
11.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chandra Bhagat Pharma Recent Developments
11.6 Taj Pharmaceuticals
11.6.1 Taj Pharmaceuticals Corporation Information
11.6.2 Taj Pharmaceuticals Overview
11.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Taj Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drugs for Schistosomiasis Industry Chain Analysis
12.2 Drugs for Schistosomiasis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs for Schistosomiasis Production Mode & Process
12.4 Drugs for Schistosomiasis Sales and Marketing
12.4.1 Drugs for Schistosomiasis Sales Channels
12.4.2 Drugs for Schistosomiasis Distributors
12.5 Drugs for Schistosomiasis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drugs for Schistosomiasis Industry Trends
13.2 Drugs for Schistosomiasis Market Drivers
13.3 Drugs for Schistosomiasis Market Challenges
13.4 Drugs for Schistosomiasis Market Restraints
14 Key Findings in The Global Drugs for Schistosomiasis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Drugs for Schistosomiasis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Praziquantel
Table 3. Major Manufacturers of Oxamniquine
Table 4. Major Manufacturers of Other
Table 5. Global Drugs for Schistosomiasis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Drugs for Schistosomiasis Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Drugs for Schistosomiasis Sales by Region (2017-2022) & (M Units)
Table 8. Global Drugs for Schistosomiasis Sales Market Share by Region (2017-2022)
Table 9. Global Drugs for Schistosomiasis Sales by Region (2023-2028) & (M Units)
Table 10. Global Drugs for Schistosomiasis Sales Market Share by Region (2023-2028)
Table 11. Global Drugs for Schistosomiasis Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Drugs for Schistosomiasis Revenue Market Share by Region (2017-2022)
Table 13. Global Drugs for Schistosomiasis Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Drugs for Schistosomiasis Revenue Market Share by Region (2023-2028)
Table 15. Global Drugs for Schistosomiasis Sales by Manufacturers (2017-2022) & (M Units)
Table 16. Global Drugs for Schistosomiasis Sales Share by Manufacturers (2017-2022)
Table 17. Global Drugs for Schistosomiasis Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Drugs for Schistosomiasis Revenue Share by Manufacturers (2017-2022)
Table 19. Drugs for Schistosomiasis Price by Manufacturers (2017-2022) &(USD/K Units)
Table 20. Global Drugs for Schistosomiasis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2021)
Table 22. Drugs for Schistosomiasis Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Drugs for Schistosomiasis Product Offered
Table 24. Date of Manufacturers Enter into Drugs for Schistosomiasis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 27. Global Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
Table 28. Global Drugs for Schistosomiasis Sales Share by Type (2017-2022)
Table 29. Global Drugs for Schistosomiasis Sales Share by Type (2023-2028)
Table 30. Global Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Drugs for Schistosomiasis Revenue Share by Type (2017-2022)
Table 33. Global Drugs for Schistosomiasis Revenue Share by Type (2023-2028)
Table 34. Drugs for Schistosomiasis Price by Type (2017-2022) & (USD/K Units)
Table 35. Global Drugs for Schistosomiasis Price Forecast by Type (2023-2028) & (USD/K Units)
Table 36. Global Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 37. Global Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
Table 38. Global Drugs for Schistosomiasis Sales Share by Application (2017-2022)
Table 39. Global Drugs for Schistosomiasis Sales Share by Application (2023-2028)
Table 40. Global Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Drugs for Schistosomiasis Revenue Share by Application (2017-2022)
Table 43. Global Drugs for Schistosomiasis Revenue Share by Application (2023-2028)
Table 44. Drugs for Schistosomiasis Price by Application (2017-2022) & (USD/K Units)
Table 45. Global Drugs for Schistosomiasis Price Forecast by Application (2023-2028) & (USD/K Units)
Table 46. North America Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 47. North America Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
Table 48. North America Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 51. North America Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
Table 52. North America Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 55. North America Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 56. North America Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 59. Europe Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
Table 60. Europe Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 63. Europe Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
Table 64. Europe Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 67. Europe Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 68. Europe Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 71. Asia Pacific Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
Table 72. Asia Pacific Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 75. Asia Pacific Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
Table 76. Asia Pacific Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Drugs for Schistosomiasis Sales by Region (2017-2022) & (M Units)
Table 79. Asia Pacific Drugs for Schistosomiasis Sales by Region (2023-2028) & (M Units)
Table 80. Asia Pacific Drugs for Schistosomiasis Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Drugs for Schistosomiasis Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 83. Latin America Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
Table 84. Latin America Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 87. Latin America Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
Table 88. Latin America Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 91. Latin America Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 92. Latin America Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2017-2022) & (M Units)
Table 95. Middle East and Africa Drugs for Schistosomiasis Sales by Type (2023-2028) & (M Units)
Table 96. Middle East and Africa Drugs for Schistosomiasis Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Drugs for Schistosomiasis Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2017-2022) & (M Units)
Table 99. Middle East and Africa Drugs for Schistosomiasis Sales by Application (2023-2028) & (M Units)
Table 100. Middle East and Africa Drugs for Schistosomiasis Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Drugs for Schistosomiasis Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2017-2022) & (M Units)
Table 103. Middle East and Africa Drugs for Schistosomiasis Sales by Country (2023-2028) & (M Units)
Table 104. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2023-2028) & (US$ Million)
Table 106. Shin Poong Corporation Information
Table 107. Shin Poong Description and Major Businesses
Table 108. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 109. Shin Poong Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Shin Poong Recent Developments
Table 111. Merck Corporation Information
Table 112. Merck Description and Major Businesses
Table 113. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 114. Merck Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Merck Recent Developments
Table 116. Bayer Corporation Information
Table 117. Bayer Description and Major Businesses
Table 118. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 119. Bayer Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Bayer Recent Developments
Table 121. EIPICO Corporation Information
Table 122. EIPICO Description and Major Businesses
Table 123. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 124. EIPICO Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. EIPICO Recent Developments
Table 126. Chandra Bhagat Pharma Corporation Information
Table 127. Chandra Bhagat Pharma Description and Major Businesses
Table 128. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 129. Chandra Bhagat Pharma Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Chandra Bhagat Pharma Recent Developments
Table 131. Taj Pharmaceuticals Corporation Information
Table 132. Taj Pharmaceuticals Description and Major Businesses
Table 133. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2017-2022)
Table 134. Taj Pharmaceuticals Drugs for Schistosomiasis Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Taj Pharmaceuticals Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Drugs for Schistosomiasis Distributors List
Table 139. Drugs for Schistosomiasis Customers List
Table 140. Drugs for Schistosomiasis Market Trends
Table 141. Drugs for Schistosomiasis Market Drivers
Table 142. Drugs for Schistosomiasis Market Challenges
Table 143. Drugs for Schistosomiasis Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 3. Global Drugs for Schistosomiasis Market Share by Type in 2021 & 2028
Figure 3. Praziquantel Product Picture
Figure 4. Oxamniquine Product Picture
Figure 5. Other Product Picture
Figure 6. Global Drugs for Schistosomiasis Market Share by Application in 2021 & 2028
Figure 7. S. haematobium
Figure 8. S. mansoni
Figure 9. S. japonicum
Figure 10. S. mekongi
Figure 11. S. intercalatum
Figure 12. Drugs for Schistosomiasis Report Years Considered
Figure 13. Global Drugs for Schistosomiasis Sales 2017-2028 (M Units)
Figure 14. Global Drugs for Schistosomiasis Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Drugs for Schistosomiasis Revenue 2017-2028 (US$ Million)
Figure 16. Global Drugs for Schistosomiasis Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Drugs for Schistosomiasis Sales Market Share by Region (2017-2022)
Figure 18. Global Drugs for Schistosomiasis Sales Market Share by Region (2023-2028)
Figure 19. North America Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
Figure 20. North America Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
Figure 22. Europe Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
Figure 24. Asia-Pacific Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
Figure 26. Latin America Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Drugs for Schistosomiasis Sales YoY (2017-2028) & (M Units)
Figure 28. Middle East & Africa Drugs for Schistosomiasis Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Drugs for Schistosomiasis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Drugs for Schistosomiasis in the World: Market Share by Drugs for Schistosomiasis Revenue in 2021
Figure 31. Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
Figure 33. Global Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
Figure 34. Global Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
Figure 35. Global Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
Figure 36. North America Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
Figure 37. North America Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
Figure 38. North America Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
Figure 39. North America Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
Figure 40. North America Drugs for Schistosomiasis Sales Share by Country (2017-2028)
Figure 41. North America Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
Figure 42. U.S. Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
Figure 45. Europe Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
Figure 46. Europe Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
Figure 47. Europe Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
Figure 48. Europe Drugs for Schistosomiasis Sales Share by Country (2017-2028)
Figure 49. Europe Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
Figure 50. Germany Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 51. France Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Drugs for Schistosomiasis Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Drugs for Schistosomiasis Revenue Share by Region (2017-2028)
Figure 61. China Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 64. India Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
Figure 72. Latin America Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
Figure 74. Latin America Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Drugs for Schistosomiasis Sales Share by Country (2017-2028)
Figure 76. Latin America Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
Figure 77. Mexico Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Drugs for Schistosomiasis Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Drugs for Schistosomiasis Revenue Share by Country (2017-2028)
Figure 86. Turkey Drugs for Schistosomiasis Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Drugs for
  • Gatifloxacin Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 14-May-2022        Price: US 3500 Onwards        Pages: 81
    This report describes the global market size of Gatifloxacin from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included su......
  • Global and United States Valganciclovir Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 77
    Valganciclovir market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Valganciclovir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Valganciclovir market size by players, by Type and by......
  • Global and United States Meningitis Vaccine Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 95
    Meningitis Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Meningitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Meningitis Vaccine market size by players, by......
  • Global and United States Analgesics Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 103
    Analgesics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Analgesics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Analgesics market size by players, by Type and by Application......
  • Global and United States Viral Vaccines Market Report & Forecast 2022-2028
    Published: 14-May-2022        Price: US 4350 Onwards        Pages: 106
    Viral Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Viral Vaccines market size by players, by Type and by......
  • (Post-pandemic Era) - Global Zika Virus Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 103
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Therapeutic Vaccines Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 100
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Solid Organ Transplant Immunosuppressant Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 114
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Orphan Drugs Market Segment Research Report 2022
    Published: 13-May-2022        Price: US 2950 Onwards        Pages: 117
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs